SUZANNE LA LANDE: Open Payments
NPI 1114477833 · BEND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$617 in 22 payments from 10 companies in 2025. Trend: 2023 $684 · 2024 $685 · 2025 $617
Food & beverage: $617
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 9 | $176 |
| Merck Sharp & Dohme LLC | 1 | $111 |
| Astellas Pharma US Inc | 1 | $98 |
| TOLMAR, INC. | 3 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $49 |
| ABBVIE INC. | 2 | $36 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Myriad Genetic Laboratories, Inc. | 1 | $18 |
| Janssen Biotech, Inc. | 1 | $17 |
| Endo USA, Inc. | 1 | $17 |
Products named: KEYTRUDA, SpaceOAR VUE System - 10mL, Xtandi, JATENZO, Rezum Generator, Nubeqa, BOTOX, GEMTESA.
Industry payments across OR — which companies pay providers there.
